Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal Cancer

Mark A. Jenkins, Daniel D. Buchanan, John Lai, Enes Makalic, Gillian S. Dite, Aung K. Win, Mark Clendenning, Ingrid M. Winship, Richard B. Hayes, Jeroen R. Huyghe, Ulrike Peters, Steven Gallinger, Loïc Le Marchand, Jane C. Figueiredo, Rish K. Pai, Polly A. Newcomb, James M. Church, Graham Casey, John L. Hopper

Research output: Contribution to journalArticlepeer-review

Abstract

It was not known whether the polygenic risk scores (PRSs) that predict colorectal cancer could predict colorectal cancer for people with inherited pathogenic variants in DNA mismatch repair genes - people with Lynch syndrome. We tested a PRS comprising 107 established single-nucleotide polymorphisms associated with colorectal cancer in European populations for 826 European-descent carriers of pathogenic variants in DNA mismatch repair genes (293 MLH1, 314 MSH2, 126 MSH6, 71 PMS2, and 22 EPCAM) from the Colon Cancer Family Registry, of whom 504 had colorectal cancer. There was no evidence of an association between the PRS and colorectal cancer risk, irrespective of which DNA mismatch repair gene was mutated, or sex (all 2-sided P >. 05). The hazard ratio per standard deviation of the PRS for colorectal cancer was 0.97 (95% confidence interval = 0.88 to 1.06; 2-sided P =. 51). Whereas PRSs are predictive of colorectal cancer in the general population, they do not predict Lynch syndrome colorectal cancer.

Original languageEnglish (US)
Article numberpkab022
JournalJNCI Cancer Spectrum
Volume5
Issue number2
DOIs
StatePublished - Apr 1 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal Cancer'. Together they form a unique fingerprint.

Cite this